Xcout Intel
Vima Therapeutics competitors & alternatives
The 12 closest competitors and alternatives to Vima Therapeutics among drug discovery companies — ranked by similarity to what Vima Therapeutics actually does, not by market-cap band.
Subscribe to see Vima Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Vima Therapeutics
Vima Therapeutics is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts. The firm pioneers treatments for dystonia and related movement disorders, focusing on novel oral therapies. It develops specialized therapeutics designed to help patients regain mobility and freedom of movement.
Vima Therapeutics at a glance
Vima Therapeutics is a drug discovery company headquartered in United States. It has raised at least $100M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $40M in March 2026. Xcout tracks 15 named people at Vima Therapeutics, including Judy Dunn (President of Research & Development).
Vima Therapeutics leadership
- Judy DunnPresident of Research & Development
- Jessica FeesChief Financial Officer
- Tushar MisraChief Technical Officer
- Ariel D. JasieChief Business Officer and General Counsel
- David GrayzelChair
- Bernard RavinaFounder and Chief Executive Officer Board Member
9 more named people on record for Vima Therapeutics, with roles, board committees and tenure — see the full roster →
Vima Therapeutics funding rounds
At least $100M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $40M | 4 named | |
| Series A | $60M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Vima Therapeutics competitors
Ranked by semantic similarity — how close each company is to Vima Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar drug discovery company
Courage Therapeutics, Inc. is a for-profit biotechnology company founded in 2019 and headquartered in Newton, Massachusetts. The company operates in the biotech sector with a focus on developing therapeutic solutions.
Similar drug discovery company
Tortugas Neuroscience is a drug discovery and biopharmaceutical company headquartered in Framingham, Massachusetts. The company focuses on advancing innovative neuroscience therapeutics.
Similar drug discovery company
Diagonal Therapeutics is a biotechnology company headquartered in Watertown, Massachusetts, pioneering disease-modifying clustering antibody therapeutics to target the root causes of devastating diseases.
Similar drug discovery company
Astria Therapeutics, Inc. is a public biopharmaceutical company headquartered in Boston, Massachusetts, dedicated to developing life-changing therapies for patients.
Similar drug discovery company
Caldera Therapeutics, Inc. is a Cambridge, Massachusetts-based clinical-stage biotechnology company focused on treatments such as a bispecific inflammatory bowel disease (IBD) asset.
Similar drug discovery company
AIRNA Corp is a biotechnology company headquartered in Cambridge, Massachusetts, focused on developing RNA editing therapeutics. Its leading program utilizes ADAR-recruiting technology to target specific RNA locations for therapeutic applications.
Similar drug discovery company
Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company headquartered in Boston, Massachusetts. The company discovers and develops Anticalin-based drugs designed to address significant medical needs.
Similar drug discovery company
Nura Bio Inc. is a privately held biopharmaceutical company headquartered in South San Francisco, California, founded in 2018 to develop novel treatments for neurological diseases.
Similar drug discovery company
Kainova Therapeutics, formerly known as Domain Therapeutics, is a clinical-stage biopharmaceutical company headquartered in Montreal, Quebec. The company drives a clinical pipeline of advanced GPCR-modulating therapies to address unmet medical needs.
Similar drug discovery company
Orbital Therapeutics is a biotechnology company developing RNA medicines, with a focus on engineered circular RNA and delivery technologies. Its programs are intended to address diseases that may benefit from durable, programmable protein expression, serving patients and healthcare providers through potential therapeutic products.
Medtech
IAMA Therapeutics is a clinical-stage pharmaceutical and biotechnology company founded in 2021 and headquartered in Genoa, Italy. The firm is dedicated to researching and developing innovative, disease-modifying medicines to treat brain disorders.
Biopharma
Engrail Therapeutics, Inc. is a clinical-stage neurosciences and pharmaceutical company established in 2019 and headquartered in San Diego, California. The firm focuses on developing novel treatments such as its planned ENX-104 clinical program.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Vima Therapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Vima Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →